Standardization of flow cytometric minimal residual disease assessment in international clinical trials - a feasibility study from the European Myeloma Network

Item request has been placed!

Item request cannot be made.

Processing Request

Read More Add to Saved list

Author(s): Op Bruinink, Davine Hofste; Oliva, Stefania; Rihova, Lucie; Schmitz, Alexander; Gilestro, Milena; Te Marvelde, Jeroen; Kralova, Romana; Høholt, Helle; Broijl, Annemiek; Johnsen, Hans Erik; Hajek, Roman; Boccadoro, Mario; Sonneveld, Pieter; Omedè, Paola; Van der Velden, Vincent H.J.
Source:
Op Bruinink , D H , Oliva , S , Rihova , L , Schmitz , A , Gilestro , M , Te Marvelde , J , Kralova , R , Høholt , H , Broijl , A , Johnsen , H E , Hajek , R , Boccadoro , M , Sonneveld , P , Omedè , P , Van der Velden , V H J & European Myeloma Network 2021 , ' Standardization of flow cytometric minimal residual disease assessment in international clinical trials - a feasibility study from the European Myeloma Network ' , Haematologica , ....
Subject Terms:
Feasibility Studies; Flow Cytometry; Humans; Multiple Myeloma/diagnosis; Neoplasm; Residual; Reference Standards
Document Type:
article in journal/newspaper
Language:
English